SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from Armata Pharmaceuticals, Inc. (ARMP) (CIK 0000921114) (ARMP) — Feb 8, 2007

Armata Pharmaceuticals, Inc. (ARMP) (CIK 0000921114)
Date: Feb. 8, 2007 · CIK: 0000921114 · Accession: 0001144204-07-005865

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-140187

Date
Feb. 8, 2007
Author
Director
Form
CORRESP
Company
Armata Pharmaceuticals, Inc. (ARMP) (CIK 0000921114)

Letter

Division of Corporation Finance Securities and Exchange Commission Attention: Song P. Brandon, Esq. Re: Targeted Genetics Corporation - Request for Acceleration of Effectiveness of Registration Statement on Form S-3, Commission File No. 333-140187

Dear Mr. Riedler,

Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Targeted Genetics Corporation (the “Company”) hereby requests that the effective date of its Registration Statement on Form S-3, Registration No. 333-140187 (the “Registration Statement”) be accelerated so that the Registration Statement may become effective at the later of: (a) 4:00 p.m., Eastern Standard Time, Thursday, February 8, 2007, or as soon as practicable thereafter; and (b) such later time as the Company may request by telephone to the Commission. The Company hereby authorizes Stephen M. Graham or Lewis S. Malakoff of Orrick, Herrington & Sutcliffe LLP, counsel for the Company, to make such a request on its behalf.

Very
truly yours,
TARGETED GENETICS
CORPORATION

Show Raw Text
CORRESP
1
filename1.htm

    [Letterhead
      of Targeted Genetics Corporation]

    February
      8, 2007

    VIA
      FACSIMILE (202-772-9217) AND EDGAR

    Mr.
      Jeffrey P. Riedler

    Assistant
      Director

    Division
      of Corporation Finance

    Securities
      and Exchange Commission

    100
      F
      Street, NE

    Washington,
      DC 20549

    Attention:
      Song P. Brandon, Esq.

            Re:

              Targeted
                Genetics Corporation - Request for Acceleration of

              Effectiveness
                of Registration Statement on Form S-3, Commission File

              No.
                333-140187

    Dear
      Mr.
      Riedler,

    Pursuant
      to Rule 461 of the General Rules and Regulations under the Securities Act of
      1933, as amended, Targeted Genetics Corporation (the “Company”)
      hereby
      requests that the effective
      date of its Registration Statement on Form S-3, Registration No. 333-140187
      (the
      “Registration
      Statement”)
      be
      accelerated so that the Registration Statement may become effective at the
      later
      of: (a) 4:00 p.m., Eastern Standard Time, Thursday, February 8, 2007, or as
      soon
      as practicable thereafter; and (b) such later time as the Company may request
      by
      telephone to the Commission. The Company hereby authorizes Stephen M. Graham
      or
      Lewis S. Malakoff of Orrick, Herrington & Sutcliffe LLP, counsel for the
      Company, to make such a request on its behalf.

              Very
                truly yours,

              TARGETED GENETICS
                CORPORATION

            /s/ David
              J.
              Poston

              David J. Poston

                Vice
                  President Finance and

                Chief Financial
                  Officer

    cc:
      Orrick,
      Herrington & Sutcliffe LLP